AOXING PHARMACEUTICAL COMPANY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0072 USD | 0.00% |
|
+80.00% | +132.26% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2015 | 2.55Cr 212.62Cr | Sales 2016 | 3.23Cr 269.76Cr | Capitalization | 4.95Cr 413.33Cr |
|---|---|---|---|---|---|
| Net income 2015 | 50L 42Cr | Net income 2016 | 20L 17Cr | EV / Sales 2015 | 5.77 x |
| Net Debt 2015 | 2.48Cr 206.97Cr | Net Debt 2016 | 1.86Cr 154.87Cr | EV / Sales 2016 | 2.11 x |
| P/E ratio 2015 |
20.1
x | P/E ratio 2016 |
23.2
x | Employees | 346 |
| Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 100% |
More Fundamentals
* Assessed data
More news
| 1 week | +80.00% | ||
| Current month | +41.18% | ||
| 1 month | +41.18% | ||
| 3 months | +1.41% | ||
| 6 months | -10.00% | ||
| Current year | +132.26% |
1 week
0.01
0.01
1 month
0.000.01
Current year
0.000.01
1 year
0.000.01
3 years
0.000.02
5 years
0.000.05
10 years
0.003.48
| Managers | Title | Age | Since |
|---|---|---|---|
David Duarte
CEO | Chief Executive Officer | - | 11/23/11 |
Gui Rong Zhou
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/11/01 |
Peng Jiang
SAM | Sales & Marketing | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Duarte
CEO | Chief Executive Officer | - | 11/23/11 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/24/16 | 0.0072 | 0.00% | 500 |
| 10/24/10 | 0.0072 | +80.00% | 150,000 |
Delayed Quote OTC Markets, May 16, 2024 at 10:57 pm IST
More quotes
Aoxing Pharmaceutical Company, Inc. is a specialty pharmaceutical company specializing in research, development, manufacturing and distribution of a range of narcotic, pain-management and addiction treatment pharmaceutical products. The Company holds approximately 140 drug production certificates covering narcotic pain-management, prescription medicines, over-the-counter (OTC) and active pharmaceutical ingredient (API) products. Its products include prescription drugs, such as Tilidine hydrochloride, Zhongtong'an and Humifuse Euphorbia Herb Tablet, and OTC drugs, such as Shanmei Capsule, Shaoshang Tincture, Yiqi Qiangshen Granule, Xiaopiling Granule, Xiongjushangqing Tablet, Juyuansuanbijia Oral Solutions, Longdanxiegan Tablet, Fenka Tablet, Shujinhuoxue Tablet, Fuketiaojing Tablet, Qingnao Jiangya Tablet, Yuanhu Pain Management Tablet, Bushenqiangshen Tablet, Baiziyangxin Pill, Qingguo Pill, Liuweidihuang Pill, Zhibaidihuang Pill, Xiaoyao Pill and Tianwangbuxin Pill.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +132.26% | 24.57L | |
| +21.98% | 4.39TCr | |
| +24.56% | 2.31TCr | |
| +19.25% | 1.53TCr | |
| +14.03% | 1.36TCr | |
| +46.40% | 1.2TCr | |
| -10.14% | 699.72Cr | |
| -0.05% | 678.76Cr | |
| -8.87% | 572.55Cr | |
| +13.88% | 559.68Cr |
- Stock Market
- Equities
- AOXG Stock